Here, we briefly review the migratory and invasive capacity of GBM cells, the contribution of ODZ1 to these processes, the mechanisms that regulate ODZ1 expression, and the therapeutic approaches to control these pathways. The gene discussed is TENM1; the disease is glioblastoma.